September 16, 2011: ACTTION Awarded 5-Year Grant From FDA

ACTTION is pleased to announce that it has received a 5-year research grant from the FDA with up to $4.5 million in funding to support its activities. Extending the FDA’s initial research contract (awarded in September 2010), this new research grant reflects the FDA’s continued support for ACTTION and constitutes a critical long-term commitment to the success of the ACTTION public-private partnership. The University of Rochester press release describing the research grant award can be found here.